Ixabepilone/epiribicin combination as therapy for metastatic breast cancer - a phase Ib study

被引：0
|
作者：
Roche, H. [1 ]
Zambetti, M. [2 ]
Dalenc, F. [1 ]
De Benedictis, E. [2 ]
Gladieff, L. [1 ]
Mudenda, B. [3 ]
Messina, M. [3 ]
Lainas, I. [4 ]
Gianni, L. [2 ]
机构：
[1] Inst Claudius Regaud, Dept Med Oncol, I-20133 Toulouse, France
[2] Ist Nazl Studio & Cura Tumori, Dept Med Oncol, Milan, Italy
[3] Bristol Myers Squibb Co, Dept Med Oncol, Wallingford, CT USA
[4] Braine Alleud, Dept Med Oncol, Brussels, Belgium
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)70915-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：267 / 268
页数：2
相关论文
共 50 条
  • [1] Phase Ib study of ixabepilone (I) in combination with epirubicin (E) in women with metastatic breast cancer
    Roche, H. H.
    Zambetti, M.
    Dalenc, F.
    Govi, S.
    Gladieff, L.
    Mudenda, B.
    Lainas, I.
    Iacono, L.
    Gianni, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [2] Phase IB trial of ixabepilone and vorinostat in metastatic breast cancer
    Luu, Thehang
    Kim, Kyu-pyo
    Blanchard, Suzette
    Anyang, Bean
    Hurria, Arti
    Yang, Lixin
    Beumer, Jan H.
    Somlo, George
    Yen, Yun
    BREAST CANCER RESEARCH AND TREATMENT, 2018, 167 (02) : 469 - 478
  • [3] Phase IB trial of ixabepilone and vorinostat in metastatic breast cancer
    Thehang Luu
    Kyu-pyo Kim
    Suzette Blanchard
    Bean Anyang
    Arti Hurria
    Lixin Yang
    Jan H. Beumer
    George Somlo
    Yun Yen
    Breast Cancer Research and Treatment, 2018, 167 : 469 - 478
  • [4] A Phase I Study of Ixabepilone in Combination With Epirubicin in Patients With Metastatic Breast Cancer
    Roche, Henri
    De Benedictis, Elena
    Cottura, Ewa
    Govi, Silvia
    Dalenc, Florence
    Locatelli, Alberta
    Deslandres, Marion
    Zambetti, Milvia
    Gladieff, Laurence
    Messina, Marianne
    Gianni, Luca
    CLINICAL BREAST CANCER, 2012, 12 (03) : 167 - 174
  • [5] Phase Ib expansion study of gedatolisib in combination with palbociclib and endocrine therapy in women with ER plus metastatic breast cancer
    Layman, Rachel
    Wesolowski, Robert
    Han, Hyo
    Specht, Jennifer M.
    Stringer-Reasor, Erica M.
    Dees, E. Claire
    Kabos, Peter
    Mayer, Ingrid A.
    Vaishampayan, Ulka
    Lu, Janice
    Gogineni, Keerthi
    Bardia, Aditya
    Schott, Anne F.
    Abu-Khalaf, Maysa
    Howkins, Doug
    Sullivan, Brian
    Gorbatchevsky, Igor
    Rugo, Hope
    CANCER RESEARCH, 2022, 82 (04)
  • [6] A phase Ib study of abemaciclib with therapies for metastatic breast cancer.
    Tolaney, Sara M.
    Beeram, Muralidhar
    Beck, J. Thaddeus
    Conlin, Alison Katherine
    Dees, Elizabeth Claire
    Dickler, Maura N.
    Helsten, Teresa L.
    Conkling, Paul R.
    Edenfield, William Jeffery
    Richards, Donald A.
    Turner, P. Kellie
    Cai, Na
    Chan, Edward Michael
    Pant, Shubham
    Becerra, Carlos
    Kalinsky, Kevin
    Puhalla, Shannon
    Rexer, Brent Neil
    Burris, Howard A.
    Goetz, Matthew P.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [7] Phase I study of ixabepilone in combination with capecitabine in Japanese patients with metastatic breast cancer previously treated with an anthracycline and a taxane.
    Watanabe, J.
    Horiguchi, J.
    Masuda, N.
    Aogi, K.
    Sato, R.
    Tokudome, T.
    Peck, R. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [8] Supporting Asian patients with metastatic breast cancer during ixabepilone therapy
    Bourdeanu, Laura
    Wong, Siu-Fun
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (03) : 383 - 396
  • [9] Efficacy and Safety of Ixabepilone Monotherapy and Ixabepilone-Capecitabine Combination in Patients with Heavily Pretreated Metastatic Breast Cancer
    Sarici, Furkan
    Aksoy, Serean
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2021, 31 (02): : 85 - 91
  • [10] Phase I trial of ixabepilone and vorinostat in metastatic breast cancer.
    Luu, Thehang H.
    Blanchard, Suzette
    Beumer, Jan Hendrik
    Anyang, Bean N.
    Somlo, George
    Mortimer, Joanne E.
    Hurria, Arti
    Yang, Lixin
    Yen, Yun
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345